Chromatin Laser Imaging Reveals Abnormal Nuclear Changes for Early Cancer Detection

TL;DR

This study introduces laser-emission microscopy (LEM) as a rapid, sensitive method for detecting early nuclear abnormalities in tissues, potentially enabling earlier cancer diagnosis than traditional methods.

Contribution

The paper demonstrates the use of LEM to identify prepolyp nuclear abnormalities in mice, revealing early chromatin changes associated with cancer risk that are undetectable by conventional techniques.

Findings

High-fat mice showed lower lasing thresholds similar to adenomas.

LEM detected nuclear abnormalities in normal-appearing tissues.

Potential for early cancer detection before observable lesions.

Abstract

We developed and applied rapid scanning laser-emission microscopy to detect abnormal changes in cell nuclei for early diagnosis of cancer and cancer precursors. Regulation of chromatins is essential for genetic development and normal cell functions, while abnormal nuclear changes may lead to many diseases, in particular, cancer. The capability to detect abnormal changes in apparently normal tissues at a stage earlier than tumor development is critical for cancer prevention. Here we report using LEM to analyze colonic tissues from mice at-risk for colon cancer by detecting prepolyp nuclear abnormality. By imaging the lasing emissions from chromatins, we discovered that, despite the absence of observable lesions, polyps, or tumors under stereoscope, high-fat mice exhibited significantly lower lasing thresholds than low-fat mice. The low lasing threshold is, in fact, very similar to that of adenomas and is caused by abnormal cell proliferation and chromatin deregulation that can potentially lead to cancer. Our findings suggest that conventional methods, such as colonoscopy, may be insufficient to reveal hidden or early tumors under development. We envision that this work will provide new insights into LEM for early tumor detection in clinical diagnosis and fundamental biological and biomedical research of chromatin changes at the biomolecular level of cancer development.